Oncotarget published an article that looks into the unexplored case of alternating the traditional cigarettes with e-cigarettes. The paper was a conclusion of a study done by environmental medicine Professor Irfan Rahman of UR School of Medicine and Dentistry. The study delved into how this new craze is worse than its predecessors and how the damage it causes to organs of smokers. According to earlier studies, scientists had perceived that the smoke emissions of cigarette are the primary cause of a smoker’s detrimental respiratory health. However, new studies indicate that there are more damaging chemicals to it than the vapor. Visit his profile on Google Scholar.
Rahman revealed that his studies showed that vapor from e-cigarettes deteriorate cells and cause them to output inflammatory proteins. The proteins cause more damage to the cells and consequently being the slow process of destroying the entire breathing system. Additionally, the flavors included in this new cigarette add to the adverse effect of using them. The study of Oncotarget which was done on a human dummy established that different flavors resulted in various levels of damage to cells.
E-cigarettes’ composition of batteries, a heating device and the cartridge that holds the liquid have a more adverse effect on oral health in comparison to traditional cigarettes. The vapors which have the infusions of unknown chemicals and nicotine that do not compare to those of its predecessors. Rahman stated that the amount and duration of smoking ultimately determine how each smoker develops oral and respiratory complications. He wishes that manufacturers would reveal all the chemicals used to users, so as to enlighten them on the effects of buying the products. Download output styles at Endnote.com
Rahman’s study was under the financial sponsorship of the National Institute of Health. Individuals who participated in the study include author Isaac K. Sundar, Fawad Jayed, Georgies E. Romanos, and Stony Brook alongside the chief researcher Rahman Irfan.
Oncotarget is a weekly peer-reviewed medical journal that publishes material regarding oncology. It began operating in 2010 and is under the editorial management of the scientists Mikhail Blagosklonny and Andrei V. Gudkov who both work at Roswell Park Cancer Institute. The two have an extensive experience in oncology and commit to putting out articles that provide the scientific world with adequate information.